Gene therapies hold immense promise for treating sight loss. These therapies use a modified, harmless virus to deliver ...

At 22, Daniel Cressy is making history as Louisiana’s first sickle cell gene therapy patient. The treatment could be a cure ...

Adolore BioTherapeutics, Inc., ("Company" or "Adolore") announced that Roy Clifford Levitt, MD, Clinical Professor at the University of Miami, Principal Investigator and Program Director of the NIH, ...

Adding a MET gene inhibitor enhances the effect of combined chemotherapy and immunotherapy in small cell lung cancer (SCLC), ...

With a strong launch underway for a bladder cancer gene therapy, Ferring Pharmaceuticals is finding the kind of commercial ...

Haematological cancers are a recognised potential side effect with Skysona and were already mentioned in a boxed warning on ...

A research team headed by the University of Zurich has developed a powerful new method to precisely edit DNA by combining ...

An interview with Philip Vanek, chief commercialization officer of the International Society for Cell & Gene Therapy (ISCT), ...

The FDA approved labeling changes for elivaldogene autotemcel (eli-cel; Skysona), a one-time gene therapy for patients with ...

An expert discusses how community-based gene therapy administration has broadened treatment options for patients with ...

The scaled adoption of cell and gene therapies demands a new era of agile, precise, and efficient quality control methods.

Gene therapy has been headline news in recent years, in part due to the rapid development of biotechnology that enables doctors to administer such treatments. Broadly, gene therapies are ...